BGNE.Beigene, LTD
Form 4: BeiGene CEO Sells Shares
Sentiment:
Insider Transaction (Form 4)
John Oyler, Chief Executive Officer and a Director of BeiGene, Ltd., sold 60,218 shares of common stock on July 10, 2026.
Summary
- Option exercise/conversion: acquired 11,698 American Depositary Shares at $36.90 ($431,656) on July 10, 2026; holds 11,698 after (Direct).
- Open-market sale: disposed of 1,493 American Depositary Shares at $296.07 ($442,028) on July 10, 2026; holds 10,205 after (Direct).
- Open-market sale: disposed of 1,314 American Depositary Shares at $297.23 ($390,561) on July 10, 2026; holds 8,891 after (Direct).
- Open-market sale: disposed of 3,074 American Depositary Shares at $298.35 ($917,133) on July 10, 2026; holds 5,817 after (Direct).
- Open-market sale: disposed of 5,143 American Depositary Shares at $298.94 ($1,537,429) on July 10, 2026; holds 674 after (Direct).
- Open-market sale: disposed of 370 American Depositary Shares at $300.12 ($111,044) on July 10, 2026; holds 304 after (Direct).
- Open-market sale: disposed of 150 American Depositary Shares at $301.18 ($45,177) on July 10, 2026; holds 154 after (Direct).
- Open-market sale: disposed of 136 American Depositary Shares at $302.19 ($41,098) on July 10, 2026; holds 18 after (Direct).
- Open-market sale: disposed of 18 American Depositary Shares at $303.03 ($5,455) on July 10, 2026 (Direct).
- Option exercise/conversion: acquired 48,520 American Depositary Shares at $36.90 ($1,790,388) on July 13, 2026; holds 48,520 after (Direct).
- Open-market sale: disposed of 798 American Depositary Shares at $301.94 ($240,945) on July 13, 2026; holds 47,722 after (Direct).
- Open-market sale: disposed of 4,584 American Depositary Shares at $302.79 ($1,387,981) on July 13, 2026; holds 43,138 after (Direct).
- Open-market sale: disposed of 26,294 American Depositary Shares at $303.83 ($7,988,777) on July 13, 2026; holds 16,844 after (Direct).
- Open-market sale: disposed of 8,438 American Depositary Shares at $304.68 ($2,570,892) on July 13, 2026; holds 8,406 after (Direct).
- Open-market sale: disposed of 846 American Depositary Shares at $305.57 ($258,508) on July 13, 2026; holds 7,560 after (Direct).
- Open-market sale: disposed of 7,240 American Depositary Shares at $306.82 ($2,221,409) on July 13, 2026; holds 320 after (Direct).
- Open-market sale: disposed of 320 American Depositary Shares at $307.40 ($98,370) on July 13, 2026 (Direct).
- Option exercise/conversion: disposed of 152,074 Share Option (Right to Buy) on July 10, 2026; holds 1,895,426 after (Direct).
- Option exercise/conversion: disposed of 630,760 Share Option (Right to Buy) on July 13, 2026; holds 1,264,666 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $18,256,808 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
John Oyler — Director, Officer (Chief Executive Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-10 | Option exercise/conversion | American Depositary Shares | 11,698 | $37 | $431.7K | 11,698 |
| 2026-07-10 | Open-market sale | American Depositary Shares | 1,493 | $296 | $442.0K | 10,205 |
| 2026-07-10 | Open-market sale | American Depositary Shares | 1,314 | $297 | $390.6K | 8,891 |
| 2026-07-10 | Open-market sale | American Depositary Shares | 3,074 | $298 | $917.1K | 5,817 |
| 2026-07-10 | Open-market sale | American Depositary Shares | 5,143 | $299 | $1.5M | 674 |
| 2026-07-10 | Open-market sale | American Depositary Shares | 370 | $300 | $111.0K | 304 |
| 2026-07-10 | Open-market sale | American Depositary Shares | 150 | $301 | $45.2K | 154 |
| 2026-07-10 | Open-market sale | American Depositary Shares | 136 | $302 | $41.1K | 18 |
| 2026-07-10 | Open-market sale | American Depositary Shares | 18 | $303 | $5.5K | 0 |
| 2026-07-13 | Option exercise/conversion | American Depositary Shares | 48,520 | $37 | $1.8M | 48,520 |
| 2026-07-13 | Open-market sale | American Depositary Shares | 798 | $302 | $240.9K | 47,722 |
| 2026-07-13 | Open-market sale | American Depositary Shares | 4,584 | $303 | $1.4M | 43,138 |
| 2026-07-13 | Open-market sale | American Depositary Shares | 26,294 | $304 | $8.0M | 16,844 |
| 2026-07-13 | Open-market sale | American Depositary Shares | 8,438 | $305 | $2.6M | 8,406 |
| 2026-07-13 | Open-market sale | American Depositary Shares | 846 | $306 | $258.5K | 7,560 |
| 2026-07-13 | Open-market sale | American Depositary Shares | 7,240 | $307 | $2.2M | 320 |
| 2026-07-13 | Open-market sale | American Depositary Shares | 320 | $307 | $98.4K | 0 |
| 2026-07-10 | Option exercise/conversion | Share Option (Right to Buy) | 152,074 | — | — | 1,895,426 |
| 2026-07-13 | Option exercise/conversion | Share Option (Right to Buy) | 630,760 | — | — | 1,264,666 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-10 | Option exercise/conversion (11,698 shares) |
| 2026-07-10 | Open-market sale (1,493 shares) |
| 2026-07-10 | Open-market sale (1,314 shares) |
| 2026-07-10 | Open-market sale (3,074 shares) |
| 2026-07-10 | Open-market sale (5,143 shares) |
| 2026-07-10 | Open-market sale (370 shares) |
| 2026-07-10 | Open-market sale (150 shares) |
| 2026-07-10 | Open-market sale (136 shares) |
| 2026-07-10 | Open-market sale (18 shares) |
| 2026-07-13 | Option exercise/conversion (48,520 shares) |
| 2026-07-13 | Open-market sale (798 shares) |
| 2026-07-13 | Open-market sale (4,584 shares) |
| 2026-07-13 | Open-market sale (26,294 shares) |
| 2026-07-13 | Open-market sale (8,438 shares) |
| 2026-07-13 | Open-market sale (846 shares) |
| 2026-07-13 | Open-market sale (7,240 shares) |
| 2026-07-13 | Open-market sale (320 shares) |
| 2026-07-10 | Option exercise/conversion (152,074 shares) |
| 2026-07-13 | Option exercise/conversion (630,760 shares) |
Keywords
insider transaction, Form 4, ONC, BeOne Medicines Ltd., bearish, John Oyler
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.